Cited by 684Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Open access

Martin, Lee J., Pan, Yan, Price, Ann C., Sterling, Wanda, Copeland, Neal G., Jenkins, Nancy A., Price, Donald L., Lee, Michael K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.4308-05.2006PMC PMC6381830

Open this paper in CoChat — free account Open PDF

Abstract

α-Synuclein (α-Syn) is enriched in nerve terminals. Two mutations in the α-Syn gene (Ala53→ Thr and Ala30→ Pro) occur in autosomal dominant familial Parkinson's disease. Mice overexpressing the human A53T mutant α-Syn develop a severe movement disorder, paralysis, and synucleinopathy, but the mechanisms are not understood. We examined whether transgenic mice expressing human wild-type or familial Parkinson's disease-linked A53T or A30P mutant α-syn develop neuronal degeneration and cell death. Mutant mice were examined at early- to mid-stage disease and at near end-stage disease. Age-matched nontransgenic littermates were controls. In A53T mice, neurons in brainstem and spinal cord exhibited large axonal swellings, somal chromatolytic changes, and nuclear condensation. Spheroid eosinophilic Lewy body-like inclusions were present in the cytoplasm of cortical neurons and spinal motor neurons. These inclusions contained human α-syn and nitrated synuclein. Motor neurons were depleted (∼75%) in A53T mice but were affected less in A30P mice. Axonal degeneration was present in many regions. Electron microscopy confirmed the cell and axonal degeneration and revealed cytoplasmic inclusions in dendrites and axons. Some inclusions were degenerating mitochondria and were positive for humanα-syn. Mitochondrial complex IV and V proteins were at control levels, but complex IV activity was reduced significantly in spinal cord. Subsets of neurons in neocortex, brainstem, and spinal cord ventral horn were positive for terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling, cleaved caspase-3, and p53. Mitochondria in neurons had terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling-positive matrices and p53 at the outer membrane. Thus, A53T mutant mice develop intraneuronal inclusions, mitochondrial DNA damage and degeneration, and apoptotic-like death of neocortical, brainstem, and motor neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4308-05.2006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“p53 can mediate mitochondrial membrane permeabilization and apoptosis by activating Bax and Bak (Chipuk et al., 2004; Leu et al., 2004).”
Background
Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders
Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,779
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,567
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,428

Show all 59 references

Research works printed but not linked: 6

Chayen J, Bitensky L, Butcher R (1973) Practical histochemistry. New York: Wiley.
2001, Int J Mol Med, 7, 455
2002, J Neurobiol, 5, 181
2002, Neurochem Res, 27, 1089
1997, J Comp Neurol, 378, 70
2000, J Biol Chem, 265, 18344

Sorted by citations

Items 401–500 of 684

Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
Mantovani, F., Zannini, A., Rustighi, A., & Sal, G. D. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.013 · Cited by 30
Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein
Liu, F., Chen, Y., Yang, Y., Yang, L., Yu, M., Zhao, J., Wu, J.-J., Huang, F., Liu, W., Ding, Z., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.050 · Cited by 26
Dietary Protective Potential of Fucoxanthin as an Active Food Component on Neurological Disorders
Chen, Y., Lü, H., Ding, Y., Liu, S., Ding, Y., Lu, B., Xiao, J., & Zhou, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08249 · Cited by 27
Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
Ugalde, C. L., Annesley, S. J., Gordon, S. E., Mroczek, K. H., Perugini, M. A., Lawson, V., Fisher, P. R., Finkelstein, D. I., & Hill, A. F. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040899 · Cited by 26
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25
Tracking extranigral degeneration in animal models of Parkinson’s disease: quest for effective therapeutic strategies
Knaryan, V. H., Samantaray, S., Gal, C. L., Ray, S. K., & Banik, N. L. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07320.x · Cited by 24
Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone
Samantaray, S., Knaryan, V. H., Gal, C. L., Ray, S. K., & Banik, N. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.007 · Cited by 25
5′-Aza-dC sensitizes paraquat toxic effects on PC12 cell
Kong, M., Ba, M., Liang, H., Ma, L., Yu, Q., Yu, T., & Wang, Y. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.001 · Cited by 25
Mouse models of Parkinson's disease associated with mitochondrial dysfunction
Pickrell, A. M., Pinto, M., & Moraes, C. T. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.002 · Cited by 27
Enforced DNA repair enzymes rescue neurons from apoptosis induced by target deprivation and axotomy in mouse models of neurodegeneration
Martin, L. J., & Wong, M. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.06.011 · Cited by 25
Self-citation
Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies
McAllum, E. J., & Finkelstein, D. I. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0809-5 · Cited by 24
Induction of Parkinson Disease-Related Proteins in Motor Neurons after Transient Spinal Cord Ischemia in Rabbits
Sakurai, M., Kawamura, T., Nishimura, H., Suzuki, H., Tezuka, F., & Abe, K. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.167 · Cited by 24
Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein
Delic, V., Griffin, J. W. D., Zivkovic, S., Zhang, Y., Phan, T.-A., Gong, H., Chaput, D., Reynes, C., Dinh, V. B., Cruz, J., et al. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8448-8 · Cited by 25
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease
Costa, G., Sisalli, M. J., Simola, N., Notte, S. D., Casu, M. A., Serra, M., Pinna, A., Feliciello, A., Annunziato, L., Scorziello, A., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00118 · Cited by 23
Extranigral Neurodegeneration in Parkinson's Disease
Samantaray, S., Butler, J. T., Ray, S. K., & Banik, N. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.002 · Cited by 24
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons
Colla, E., Panattoni, G., Ricci, A., Rizzi, C., Rota, L., Carucci, N. M., Valvano, V., Gobbo, F., Capsoni, S., Lee, M. K., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.004 · Cited by 23
Self-citation
Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
Vermilyea, S., Christensen, A., Meints, J. P., Singh, B., Martell-Martinez, H. A., Karim, M. R., & Lee, M. K. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00309-x · Cited by 23
Self-citation
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
Roberts, B., Theunissen, F., Mastaglia, F. L., Akkari, P. A., & Flynn, L. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169364 · Cited by 25
The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease
Li, H., Liu, D., Zhang, Y.-B., Rong, H., & Zhang, X. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107122 · Cited by 25
Assessment of DNA damage and repair efficiency in drug naïve schizophrenia using comet assay
Muraleedharan, A., Menon, V., Rajkumar, R. P., & Chand, P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.018 · Cited by 23
A Novel Non‐Apoptotic Role of Procaspase‐3 in the Regulation of Mitochondrial Biogenesis Activators
Kim, J., Ha, J., Yang, S., & Son, J. H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26186 · Cited by 23
A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies
Ryskalin, L., Busceti, C. L., Limanaqi, F., Biagioni, F., Gambardella, S., & Fornai, F. (2017) · Current Protein and Peptide Science · doi:10.2174/1389203718666171117110028 · Cited by 23
Induction of parkinsonism‐related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene
Morimoto, N., Nagai, M., Miyazaki, K., Ohta, Y., Kurata, T., Takehisa, Y., Ikeda, Y., Matsuura, T., Asanuma, M., & Abe, K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22341 · Cited by 23
Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity
Vázquez-Vélez, G. E., Gonzales, K. A., Revelli, J.-P., Adamski, C. J., Alavi Naini, F., Bajić, A., Craigen, E., Richman, R., Heman-Ackah, S. M., Wood, M. J. A., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1076-19.2019 · Cited by 22
“Furthermore, haploinsufficiency in GBA1 increases PD risk due to defects in the lysosomal clearance of -Syn (Mazzulli et al., 2011).”
Background
Dementia associated with disorders of the basal ganglia
Vitanova, K. S., Stringer, K. M., Benítez, D. P., Brenton, J., & Cummings, D. M. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24508 · Cited by 24
Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values
El-Ansary, A. K., Alhakbany, M. A., Al-Dbass, A. M., Qasem, H., Al-Mazidi, S. H., Bhat, R. S., & AL-Ayadhi, L. Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01578-7 · Cited by 22
Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson’s disease patient-derived iPSCs
Patikas, N., Ansari, R. A., & Metzakopian, E. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.06.001 · Cited by 24
Tetrahydroxystilbene glucoside inhibits α-synuclein aggregation and apoptosis in A53T α-synuclein-transfected cells exposed to MPP+
Zhang, R., Sun, F., Zhang, L., Sun, X., & Li, L. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0209 · Cited by 22
Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
Bajracharya, R., Youngson, N. A., & Ballard, J. W. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081850 · Cited by 24
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Distribution of α-synuclein in normal human jejunum and its relations with the chemosensory and neuroendocrine system
Casini, A., Mancinelli, R., Mammola, C. L., Pannarale, L., Chirletti, P., Onori, P., & Vaccaro, R. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3310 · Cited by 23
Lewy Body Disorders
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 22
Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson’s Disease
Behl, T., Kaur, G., Sehgal, A., Zengin, G., Singh, S., Ahmadi, A., & BUNGAU, S. G. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524152817 · Cited by 22
A role for zinc transporter gene SLC39A12 in the nervous system and beyond
Davis, D. N., Strong, M. D., Chambers, E., Hart, M. D., Bettaieb, A., Clarke, S. L., Smith, B. J., Stoecker, B. J., Lucas, E. A., Lin, D., et al. (2021) · Gene · doi:10.1016/j.gene.2021.145824 · Cited by 22
[18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease
Campoy, A., Liang, C., Ladwa, R. M., Patel, K. K., Patel, I. H., & Mukherjee, J. (2021) · Molecules · doi:10.3390/molecules26237360 · Cited by 20
OXPHOS toxicogenomics and Parkinson's disease
López‐Gallardo, E., Iceta, R., Iglesias, E., Montoya, J., & Ruiz‐Pesini, E. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.06.004 · Cited by 19
Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
Mendritzki, S., Schmidt, S., Sczepan, T., Zhu, X., Segelcke, D., & Lübbert, H. (2010) · Parkinson s Disease · doi:10.4061/2010/375462 · Cited by 20
Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced α-synuclein membrane interaction
Ericsson, M., von Saucken, V. E., Newman, A. J., Doehr, L., Hoesch, C., Kim, T., & Dettmer, U. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147349 · Cited by 18
Metabolites of Purine Nucleoside Phosphorylase (NP) in Serum Have the Potential to Delineate Pancreatic Adenocarcinoma
Vareed, S. K., Bhat, V. B., Thompson, C., Vasu, V. T., Fermin, D., Choi, H., Creighton, C. J., Gayatri, S., Lan, L., Putluri, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017177 · Cited by 20
Oxidative Stress in Neurodegenerative Diseases and Ageing
Pereira, M. D., Książek, K., & Menezes, R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/796360 · Cited by 19
The role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19
[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy
Mondal, R., Campoy, A., Liang, C., & Mukherjee, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.676257 · Cited by 19
Predominant Neuritic Pathology Induced by Viral Overexpression of α-Synuclein in Cell Culture
Zach, S., Büeler, H., Hengerer, B., & Gillardon, F. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9141-5 · Cited by 19
The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review
Brash-Arias, D., García, L. I., Pérez-Estudillo, C. A., Rojas-Durán, F., Aranda-Abreu, G. E., Herrera‐Covarrubias, D., & Chi-Castañeda, D. (2024) · NeuroSci · doi:10.3390/neurosci5010005 · Cited by 20
The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031845 · Cited by 18
Mitochondrial disfunction in Parkinson's disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20115703246 · Cited by 18
Early Exposure to Paraquat Sensitizes Dopaminergic Neurons to Subsequent Silencing of PINK1 Gene Expression in Mice
Zhou, H., Huang, C., Tong, J., & Xia, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1180 · Cited by 18
Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management
Sola, P., Krishnamurthy, P. T., Chintamaneni, P. K., Pindiprolu, S. K. S. S., & Kumari, M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1779218 · Cited by 19
Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson’s Disease
Stanojlović, M., Pallais, J. P., & Kotz, C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020795 · Cited by 19
Rab7 reduces α-synuclein toxicity in rats and primary neurons
Szegő, É. M., Szegő, É. M., den Haute, C. V., Höfs, L., Baekelandt, V., der Perren, A. V., & Falkenburger, B. H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113900 · Cited by 18
Iptakalim ameliorates MPP+‐induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoKATP channels
Zhang, S., Ding, J., Zhou, F., Wang, Z., Zhou, X., & Hu, G. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21931 · Cited by 18
Formation of covalent di-tyrosine dimers in recombinant α-synuclein
van Maarschalkerweerd, A., Pedersen, M., Peterson, H., Nilsson, M., Nguyen, T., Skamris, T., Rand, K. D., Vetri, V., Langkilde, A. E., & Vestergaard, B. (2015) · Intrinsically Disordered Proteins · doi:10.1080/21690707.2015.1071302 · Cited by 18
Motor Neurons Pathology After Chronic Exposure to MPTP in Mice
Vivacqua, G., Biagioni, F., Busceti, C. L., Ferrucci, M., Madonna, M., Ryskalin, L., Yu, S., D’Este, L., & Fornai, F. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00121-y · Cited by 18
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18
Neurodegenerative disorders: Dysregulation of a carefully maintained balance?
Swart, C., Haylett, W. L., Kinnear, C. J., Johnson, G., Bardien, S., & Loos, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.003 · Cited by 19
Modelling early responses to neurodegenerative mutations in mice
Gilley, J., Adalbert, R., & Coleman, M. P. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390933 · Cited by 17
Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment
Carriere, C. H., Kang, N. H., & Niles, L. P. (2016) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2016.12.007 · Cited by 17
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies
Vivacqua, G., Casini, A., Vaccaro, R., Salvi, E. P., Pasquali, L., Fornai, F., Yu, S., & D’Este, L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.03.001 · Cited by 16
Pathways of Methamphetamine Toxicity
Ferrucci, M., Pasquali, L., Paparelli, A., Ruggieri, S. A., & Fornai, F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.013 · Cited by 17
Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons
Pathak, D., Berthet, A., Bendor, J., Yu, K., Sellnow, R. C., Orr, A. L., Nguyen, M. K., Edwards, R. H., Manfredsson, F. P., & Nakamura, K. (2017) · eNeuro · doi:10.1523/eneuro.0216-16.2017 · Cited by 16
Mitochondrial-Associated Membranes in Parkinson’s Disease
Hattori, N., Arano, T., Hatano, T., Mori, A., & Imai, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_12 · Cited by 15
p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1
Won, S.-Y., Park, J., You, S.-T., Hyeun, J.-A., Kim, H. K., Jin, B. K., McLean, C., Shin, E., & Kim, E. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05030-1 · Cited by 18
Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice
Broome, S. T., & Castorina, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123174 · Cited by 15
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective
Sturchio, A., Rocha, E. M., Kauffman, M., Marsili, L., Mahajan, A., Saraf, A., Vizcarra, J. A., Guo, Z., & Espay, A. J. (2024) · Brain Sciences · doi:10.3390/brainsci14020151 · Cited by 18
Crosslink between mutations in mitochondrial genes and brain disorders: implications for mitochondrial-targeted therapeutic interventions
Kalra, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343884 · Cited by 16
α‐Synuclein induces deficiency in clathrin‐mediated endocytosis through inhibiting synaptojanin1 expression
Song, D., Yuan, L., Cui, N., Feng, C., Meng, L., Wang, X., Xiang, M., Liu, D., Wang, C., Zhang, Z., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15974 · Cited by 16
Pathology of Neurodegenerative Diseases
Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16
Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H ß-synuclein
Sekigawa, A., Fujita, M., Sekiyama, K., Takamatsu, Y., Hatano, T., Rockenstein, E. M., Spada, A. R. L., Masliah, E., & Hashimoto, M. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-34 · Cited by 15
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Diaw, S. H., Borsche, M., Streubel-Gallasch, L., Dulovic‐Mahlow, M., Hermes, J., Lenz, I., Seibler, P., Klein, C., Brüggemann, N., Vos, M. H., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00584-z · Cited by 14
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease
Pasquali, L., Ienco, E. C., & Fornai, F. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_170 · Cited by 15
Age-related tolerance to paraquat-induced parkinsonism in Drosophila melanogaster
Neves, P. F. R., Milanesi, B. B., Paz, L. V., Monteiro, V. A. C. D. M., Neves, L. T., da Veiga, L. C., da Silva, R. B., Sulzbach, J. H., Knijkik, G. P., Ribeiro, E. C. D. R., et al. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.03.010 · Cited by 13
More than a Rumor Spreads in Parkinson's Disease
Prymaczok, N. C., Riek, R., & Gerez, J. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00608 · Cited by 15
The protective effects of ethanolic extract of Clematis terniflora against corticosterone-induced neuronal damage via the AKT and ERK1/2 pathway
Noh, Y., Cheon, S., Kim, I. H., Kim, I., Lee, S., Kim, D., & Jeong, Y. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.8.099 · Cited by 14
Neonatal Brain Injury and Genetic Causes of Adult-Onset Neurodegenerative Disease in Mice Interact With Effects on Acute and Late Outcomes
Martin, L. J., Wong, M., & Hanaford, A. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00635 · Cited by 15
Self-citation
Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine
Antonini, R., Scaini, G., Michels, M., Matias, M. B. D., Schuck, P. F., Ferreira, G. C., de Oliveira, J., Dal‐Pizzol, F., & STRECK, E. L. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00525-x · Cited by 12
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Shen, W., Jiang, L., Zhao, J., Wang, H., Hu, M., Chen, L., & Chen, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15566 · Cited by 13
Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?
Aspholm, E. E., Matečko‐Burmann, I., & Burmann, B. M. (2020) · Life · doi:10.3390/life10110289 · Cited by 13
Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests
Gubinelli, F., Cazzolla, G., Negrini, M., Kulacz, I., Mehrdadian, A., Tomasello, G., Venuti, C., Sarauskyte, L., Jacobs, F., Manfredsson, F. P., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113887 · Cited by 14
Deafferentation-induced caspase-3 activation and DNA fragmentation in chick cochlear nucleus neurons
Karnes, H. E., Kaiser, C. L., & Durham, D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.031 · Cited by 12
Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse model
Zhang, Z., Wang, R., Zhou, H., Wu, D., Cao, Y., Zhang, C., Sun, H., Mu, C., Hao, Z., Ren, H., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05176-5 · Cited by 15
Animal Models of Gastrointestinal Problems in Parkinson's Disease
Greene, J. G. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11033 · Cited by 13
Tackling neurodegenerative diseases: animal models of Alzheimer’s disease and Parkinson’s disease
Raslan, A., & Kee, Y. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0116-2 · Cited by 12
The metabolomics of alpha-synuclein (SNCA) gene deletion and mutation in mouse brain
Musgrove, R. E., Horne, J., Wilson, R., King, A. E., Edwards, L. M., & Dickson, T. C. (2013) · Metabolomics · doi:10.1007/s11306-013-0561-6 · Cited by 12
Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
Han, J., Shin, C., & Choi, Y. P. (2021) · Viruses · doi:10.3390/v13050759 · Cited by 12
Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis
Wang, Y., Pan, Y. H., Price, A. C., & Martin, L. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-75 · Cited by 13
Self-citation
The Role of Neuroinflammation in Parkinson's Disease
Chen, X., & Tansey, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00018-6 · Cited by 12
β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson’s Disease
Xian, M., Li, J., Liu, T., Hou, K., Sun, L., & Wei, J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00263 · Cited by 11
⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis
Sagredo, G. T., Tanglay, O., Shahdadpuri, S., Fu, Y., & Halliday, G. M. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114887 · Cited by 13
Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Ali, I., Adil, M., Imran, M., Qureshi, S. A., Qureshi, S., Hasan, N., & Ahmad, F. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01799-8 · Cited by 11
Mitochondrial Diseases as Model of Neurodegeneration
Selim, L., & Hassaan, H. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_8 · Cited by 11
Promising molecular targets for pharmacological therapy of neurodegenerative pathologies
Неганова, М. Е., Aleksandrova, Y. R., Nebogatikov, V. O., Klochkov, S. G., & Ustyugov, A. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10925 · Cited by 11
α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin
Maor, G., Dubreuil, R. R., & Feany, M. Β. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1922-22.2022 · Cited by 13
Prosurvival effect of human wild-type α-synuclein on MPTP-induced toxicity to central but not peripheral catecholaminergic neurons isolated from transgenic mice
Pérez‐Sánchez, F., Milán, M., Buendía, P., Cano‐Jaimez, M., Ambrosio, S., Rosenthal, A., & Fariñas, I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.016 · Cited by 12
Localization of α‐Synuclein in Teleost Central Nervous System: Immunohistochemical and Western Blot Evidence by 3D5 Monoclonal Antibody in the Common Carp,Cyprinus carpio
Vaccaro, R., Toni, M., Casini, A., Vivacqua, G., Yu, S., D’Este, L., & Cioni, C. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23722 · Cited by 11
KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity
Fonseca-Fonseca, L. A., Núñez-Figueredo, Y., Ramírez-Sánchez, J., Guerra, M. W., Ochoa, E., Verdecia-Reyes, Y., Delgado, R., Menezes-Filho, N. J., Costa, T. C. S., de Santana, W. A., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9851-5 · Cited by 11
Animal Models of Parkinson's DiseasePreprint
Dawson, V. L., & Dawson, T. M. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041644 · Cited by 12
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
Sanluca, C., Spagnolo, P., Mancinelli, R., Bartolo, M. I. D., Fava, M., Maccarrone, M., Carotti, S., Gaudio, E., Leuti, A., & Vivacqua, G. (2024) · Metabolites · doi:10.3390/metabo14070352 · Cited by 9
Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy
Enoru, J. O., Yang, B. C., Krishnamachari, S., Villanueva, E., DeMaio, W., Watanyar, A., Ramesh, C., Arterburn, J. B., & Perez, R. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162162 · Cited by 10
Etiology and Pathogenesis of Parkinson’s Disease
Miranda, B. R. D., & Greenamyre, J. T. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00001 · Cited by 11
Immunotherapies for Parkinson’s Disease: Progression of Clinical Development
Teng, J. S., Ooi, Y. Y., Chye, S. M., Ling, A. P. K., & Koh, R. Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210526160926 · Cited by 10

Authors: Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
ORCID: Martin, Lee J.
Jenkins, Nancy A.
Lee, Michael K.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-01-04
Volume: 26
Issue: 1
Pages: 41-50
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.4308-05.2006
PMC: PMC6381830
OpenAlex: W2084910880
Cited by: 684
References: 59
Citations by year: 2026: 15 · 2025: 14 · 2024: 24 · 2023: 27 · 2022: 37 · 2021: 34 · 2020: 27 · 2019: 34 · 2018: 39 · 2017: 43 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 41 · 2012: 49
FWCI: 26.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (NS38377)
U.S. Public Health Service
National Institute on Aging (AG 16282, R01AG016282)
National Institute of Neurological Disorders and Stroke (NS 38377, R01NS052098, NS34 100, P01NS038065, R56NS038065, P50NS038377, NS 38065, R01NS034100, R01NS038065, NS52098)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: alpha-synuclein, Parkinson's disease, A53T mutation, A30P mutation, transgenic mice, mitochondrial degeneration, neuronal cell death, motor neuron degeneration, axonal degeneration, Lewy bodies, mitochondrial DNA damage, apoptosis, caspase-3, p53, mitochondrial complex IV, synucleinopathies
MeSH terms: Alanine, Animals, Brain Stem, DNA Damage, Humans, Mice, Transgenic, Mitochondria, Mutation, Nerve Degeneration, Parkinson Disease, Threonine, Cell Death, Neocortex, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks